Clinicians who work with stroke patients are beginning to look at robotics and other innovative technologies in rehabilitation that could allow for more treatments without increasing staffing. Young companies with products in development compete with established players in this market, which eventually could become more important to providers as reform efforts move ahead.

CMS on Aug. 1 formally adopted two policies from the health care reform law that will have significant implications for its long-term approach to value-based reimbursement.

FDA last week finalized a three-year-old proposal to down-classify Medical Device Data Systems to class I, or low-risk, medical devices exempt from pre-market review.